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1. Introduction 
It has been well established that excessive ethanol consumption is associated with an 
increased risk of cancers in various organs (Bann et al. 2007). It is estimated that alcohol 
consumption accounts for 3.6% of all cancer cases and 3.5% of cancer deaths in the world 
(Boffetta et al. 2006). However, the mechanisms by which ethanol causes cancer remains 
obscure.  
Recently, aberrant statuses of retinoids, which are structurally and/or functionally related to 
vitamin A (retinol), have been implicated in the pathogenesis of some types of cancers. It is 
well established that, at least in natural conditions, retinoic acids (RAs) are mainly 
responsible for retinoid actions among various retinoids. A current consensus is that RAs 
are supplied via retinol metabolisms in vivo.  
Both retinol and ethanol are types of alcohol. Thus, features of their metabolic pathways are 
similar to each other. The aim of this chaper is to summarize the latest knowledge on the 
supply pathway of RA in vivo and that on carcinogenesis due to short supply of RA. 
Moreover, we recently suggested that in situ RA supply was disturbed by ethanol 
metabolism in esophageal mucosa, and hypothesized that this could account for the 
pathogenesis of esophageal cancer seen in alcoholics. In this chapter, we also discussed how 
this hypothesis could be fit to the clinical characteristics of esophageal cancer seen in 
alcoholics. Since many of the views introduced in this chapter are obtained from animal 
models, we must interpret them carefully. However, we believe that most of these views are 
fully applicable for clinical cases.  
2. Cancers in heavy drinkers and their characteristics 
2.1 Organ specificities in cancers related to ethanol consumption  
Many reports suggest that ethanol consumption could be a risk factor for malignancies of 
multiple organs (Alcohol and Cancer- Widipeda, http://en.wikipedia.org/wiki/ Alcohol_ 
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and_ cancer). However, the current consensus, established by a meeting of the International 
Agency for Research on Cancer (IARC) in 2007, is as follows: Alcohol beverages are 
definitely carcinogenic to humans and they contribute to the development of human cancers 
in the oral cavity, pharynx, larynx, esophagus, liver, colorectum, and the female breast, but 
they are not related to the development of human renal cell cancer and non-Hodgkins 
lymphoma (Bann et al. 2007). Currently, it is acceptable to assume that alcoholic beverages 
could be carcinogenic but there are apparent organ specific susceptibilities to the 
carcinogenicity of ethanol, and the esophagus is one of these susceptive organs.  
2.2 Genetic variations and cancers related to ethanol consumption 
Imbibed ethanol is metabolized mainly by an NAD-dependent mechanism in vivo. In this 
pathway, ethanol is oxidized to acetaldehyde, which is further oxidized to acetate (Lieber 
1984). This process is performed mainly in the liver where alcohol dehydrognease 1 (ADH1), 
comprising ADH1A, 1B, and 1C, is responsible for ethanol oxidation to acetaldehyde and 
aldehyde dehydrogenase 2 (ALDH2) is responsible for acetaldehyde oxidation to acetate. 
Among these enzymes, genetic variations of ADH1C and ALDH2 are known to affect 
ethanol metabolism. ADH1C includes two polymorphisms i.e., ADH1C*1 and ADH1C*2, 
encoding γ1 and γ2 subunits, respectively. The Kcat values for ethanol of γ1γ1 
and γ2γ2 isoforms were shown to be 87 min -1 and 35 min -1 , respectively (Bosron and Li, 
1987), indicating that the former catalyzes ethanol faster than the latter, such that the former 
produces larger amounts of acetaldehyde than the latter during a constant period when they 
encounter the same amount of ethanol. On the other hand, ALDH2 also includes two 
distinct polymorphisms i.e. ALDH2*1 and ALDH2*2, and the latter encodes a variant 
subunit of ALDH2 lacking catalytic activity for acetaldehyde. This variant is often seen in 
Asians but is rare in other races (Goedde, 1992). Most homozygous carriers of this allele are 
non-drinkers, since they can not oxidize acetaldehyde and can not complete ethanol 
metabolism in vivo. Thus, they are hardly exposed to the harmful effects associated with 
ethanol consumption including carcinogenesis. Heterozygous carriers of ALDH 2*1 / 2*2, 
who account for around 40% of the population in some Asian countries, including Japan, 
can consume alcohol beverages. However, since the catalytic activity for acetaldehyde in the 
heterozygous carriers is around 10% of that of homozygous carriers of ALDH2*1/2*1 
(Thomasson et al. 1993), significant acetaldehyde accumulation, of which symptoms are 
represented by the flushing phenomenon, occurs after drinking. Importantly, the risks of 
several cancers, including esophageal cancer seen in alcoholics, have been reported to be 
higher in alcoholics having the variant ADH1C*1 (Homann et al. 2006) and ALDH2*2 
(Yokoyama et al. 1996). However, contradictory findings have also been published for the 
ADH1C*1 variant (Brennan et al. 2004) and a consensus statement of a meeting of IARC in 
2007 only accepted a higher risk of cancer in subjects with the ALDH2*2 variant (Bann et al. 
2007). At any rate, genetic differences in ethanol-oxidizing enzymes, which alter in vivo 
acetaldehyde levels after drinking affect the inceidence of cancers in alcoholics.  
2.3 Field cancerization in cancer related to ethanol consumption  
The concept of field cancerization has been recognized. Namely, during the development of 
some cancers, such as that in aerodigestive organs, some genetic alterations which are 
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peculiar to cancer cells occur not only in cancer cells, but also in non-cancer cells adjacent to 
the malignant tumor, or in advanced pre-malignant lesions in cancer-free patients (Hong et 
al. 1995). Alteration of the p53 gene and accumulation of its protein are typical observations 
seen in field cancerization (Shin et al. 1994). The fact that a mutated p53 protein has a longer 
half-life compared to that of wild-type p53 may account for its accumulation (Gao et al. 
1994). The field cancerization has been confirmed in human esophageal mucosa (Gao et al. 
1994), and furthermore, in that of alcoholics (Yokoyama et al. 2011). Namely, it is fully 
expected that esophageal cancer develops in a manner of field concerization in some 
alcoholcs..  
2.4 Animal models of cancers related to ethanol consumption 
There are several lines of animal models demonstrating the carcinogenicity of ethanol, 
however, in most models, cancers were produced by the combination of ethanol and other 
carcinogens. Notably, Sofferitti et al. demonstrated that the administration of 10% ethanol 
ad libitum for 104-152 weeks alone could  produce cancers in Sprague-Dawley rats, 
including breeders and offspring. They demonstrated that ethanol consumption increased 
the risk of head and neck cancers. However, other cancers, which were induced by this 
model, were different from those seen in human alcoholics, for example, interstitial cell 
adenocarcinoma of the testis, Sertoli cell tumor in the ovary, uterus carcinoma, 
pheochromoblastoma, and head osteosarcoma (Soffritti et al. 2002). Moreover, at least in 
their model, ethanol administration did not affect the incidence of cancers of the esophagus, 
lung, colorectum, breast, and liver, which are now regarded as related to ethanol 
consumption in humans (Bann et al. 2007). These observations indicate that ethanol is also 
carcinogenic in the rat, however, the features are different from those in humans. There 
seems to be strain specific susceptibilities to the carcinogenicity of imbibed ethanol. On the 
other hand, one paper demosntrated that the administration of acetaldehyde vapour 
produced various lesions in the respiratory epithelium including squamous metaplasia and 
squamous cell carcinoma (Feron et al. 1986).  
3. In vivo dynamics of vitamin A for the production of RA  
Molecules which are structurally and/or functionally related to vitamin A (retinol) are 
called retinoids. Presently, over 4000 retinoids including natural and synthetic ones have 
been identified. They are biologically important since they participate in the regulation of 
various phenomenon of life. Since mammals can not synthesize retinoids in vivo, they must 
take them from foods. The current consensus is that the effects of retinoids are mainly 
attributable to retinoic acids (RAs). In spite of the large demands for RAs in tissues, its 
serum level has been reported to be just 2-3 ng/ml (Moulas et al., 2006). This level was too 
low to satisfy all in vivo demands, suggesting the existence of a compensatory supply system 
in situ. And, recently, it became clear as to how RAs were produced from retinol in situ. The 
following is a summary of recent knowledge as to in vivo retinoid dynamics.  
3.1 Absorption, storage, and delivery of retinol to a target cell  
Food contains retinol, retinyl ester, and β-carotene, which are absorbed in the small 
intestine. When intestinal epithelial cells absorb retinyl esters, they are converted into retinol 
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via retinyl ester hydrolase (REH) in situ. β-carotene is cleaved to retinal via β−β−carotene-
15,15’ monooxygenase and the retinal formed is converted into retinol via retinol 
dehydrogenase. Retinol, then, binds to celluar retinol binding protein (CRBP), which 
contributes to the stabilization of retinol and its solubilization in the aqueous phase. In turn, 
this complex is converted to retinyl esters via lecithin retinol acetyltransferase (LRAT). 
Retinyl esters formed are released into blood vessels and transported to the liver. In 
hepatocytes, retinyl esters are converted into retinol via REH, and the retinol forms a retinol-
CRBP complex with CRBP. A part of this complex is transported to hepatic stellate cells, 
which are major storage sites of retinol in vivo. There, the retinol-CRBP complex is converted 
to retinyl esters again via LRAT for storage. Upon in vivo requests for retinol, they are 
converted back to the retinol-CRBP complex via REH, which is returned to the hepatocytes. 
Recently, Bcmo1, an enzyme, which participates in β-carotene metabolism, was shown to be 
highly expressed in hepatic stellate cells, suggesting that they also contribute to β-carotene 
metabolism (Shmarakov 2010). Further studies are necessary to clarify the significance of 
this enzyme in stellate cells. In hepatocytes, CRBP of the retinol-CRBP complex is converted 
to serum retinol-binding protein (sRBP or RBP4). The retinol-RBP4 complex is released from 
the liver into blood vessels, and is delivered to retinoid target cells. In blood vessels, 
transthyretin (TTR) binds to the retinol-RBP complex, preventing efflux of the complex 
from the kidney. These features are summarized in Figure 1. 
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Retinol=CRBP
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Retinol, retinyl esters, and β-carotene in food are absorbed mainly by the small intestine and stored in 
hepatic stellate cells. Retinol binds to retinol binding protein (RBP) -4 in the liver and transthyretin 
(TTR) in blood vessels and is delivered to target cells. [CRBP; cellular retinol binding protein, RDH; 
retinol dehydrogenase LRAT; lecithin retinol acetyltransferase, REH; retinyl ester hydrolase] 
Fig. 1. Absorption, storage, and delivery to a target cell of retinol. 
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3.2 RA formation from retinol in RA target cell 
A cell which requires RA, namely a RA target cell usually expresses a receptor for RBP4, 
named “stimulated by retinoic acid 6 (STRA6)“, on its surface and their combination allows 
for the retinol-RBP4-TTR complex to bind to the cell curface. From the complex, the cell 
incorporates only retinol by the action of LRAT. A part of free retinol binds to CRBP, 
forming a retinol-CRBP complex in the cell. Since the CRBP-1 gene has a binding site for 
RAR-α at its promoter region, it may be up-regulated by RA, suggesting that the protein 
contributes to retinol storage when RA is over supplied in the cell. On the other hand, free 
retinol is converted to RA via a two step oxidation process in which retinol is first oxidized 
to retinal via retinol dehydrogenase (RDH), and is then oxidized to RA via retinal 
dehydrogenase (RalDH). The formed RA binds to a cellular RA binding protein (CRABP), 
which may contribute to RA storage in the cell. The formation of a RA-CRABP complex may 
also facilitate the migration of RA from the cytosol into the nucleus, and the formation of 
RA-RA receptor complex binding to RA target genes. Free RA is further catalyzed to 4-
hydroxyl-retinoic acid (4-OH-RA), 18-hydroxy-retinoic acid (18-OHRA), 4-oxo-retinoic acid 
((4-oxo-RA), and 5,6-epoxy-retinoic acid (5,6-epoxy-RA) in the cell via Cyp26A, B, and C, 
enzymes of a P450 familiy. Among these RA metabolites, 4-oxo-RA has been shown to have 
RA activity (Baron et al.). These features are summarized in Figure 2.  
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A cell incorporates retinol from a Retinol-RBP4-TTR complex in blood vessels via STRA6. Retinol is 
metabolized to retinoic acid (RA) via a two step oxidation process. RA binds to a cellular retinoic acid 
binding protein (CRABP), and is transferred into the nucleus, when it exhibits its action. 4-oxo-RA, a 
metabolite of RA, may also have a RA effect. [CRBP; cellular retinol binding protein, RDH; retinol 
dehydrogenase RalDH; retinal dehydrogenase, RBP4; retinol binding protein 4, TTR; transthyretin, 
LRAT; lecithin retinol acetyltransferase] 
Fig. 2. Retinoic acid formation from retinol in a retinoic acid target cell. 
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4. RA and gene expression 
4.1 RA receptors 
When RA is transported into the nucleus, it binds to RA receptors which usually bind to 
the promoter regions of RA target genes. They comprise two classes, i.e. retinoic acid 
receptors (RAR) and retinoid X receptors (RXR), and each comprises three subtypes 
designated as α, β, γ, respectively. Furthermore, each subtype has several isoforms, 
namely two isoforms of RARα (α1, α2), five isoforms of RARβ (β1−β4  and β1’), two 
isoforms of RARγ (γ1, γ2), and two isoforms of RXRα (α1, α2), two isoforms of RXRβ 
(β1, β2), and two isoforms of RXRγ (γ1, γ2). RARs have affinity to all-trans and 9-cis RA, 
and RXRs have affinity to 9-cis RA. They show cDNA sequence homology with receptors 
of vitamin D, glucocorticoid, and estrogen. RXR can form homodimers with RXR and 
heterodimers with RAR. Furthermore, RXR can form heterodimers with peroxisomal 
proliferation activated receptors (PPAR), farnesoid X receptors (FXR), liver X receptors 
(LXR), pregnant X receptors (PXR), constitutive androstane receptors (CAR), and vitamin 
D receptors (VDR). In these cases, RA, especially 9-cis RA, may regulate gene expression 
with the other regulators which are originally required by partner receptors, namely fatty 
acid, bile acid, oxysterol, some xenobiotics, vitamin D, and their analogs, except for the 
cases where RXR is non-functional. Notably, the RXR-RXR homodimer was shown to 
activate PPARs (Ijpenberg et al.2004) 
4.2 Gene regulation by RA 
RA regulates gene transcription via multiple mechanisms. The simplest way is that RA 
directly affects transcription of the target gene via RA receptors. The hetero- or homo- dimer 
of RA receptors, i.e., RXR-RXR, RAR-RAR, or RXR-RAR, binds to the RA DNA Response 
Element (the specific sequence of GGTTCA(N5)AGTTCA, RARE), usually located at the 
promoter region of the target gene. When RA and co-activators, such as the pCIP/p300 
complex, binds to the dimer, gene transcription starts under the presence of RNA 
polymerase II. This condition is schematically illustrated in Figure 3.  
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When RA binds to RARE, located at the 5’ region of a gene via RA receptors, gene transcription starts. 
For this event, co-activators, such as a pCIP/p300 complex and RNA polymerase II, are required.  
Fig. 3. Regulation of gene transcription by RA (1).  
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There are several lines of evidence to suggest that the functions of RARs are also regulated 
by their phosphorylation statuses. The enzymes responsible for their phosporylation 
processes remain obscure. However, observations suggest that regulation of gene 
transcription by RA is not a simple event in such a simple model. The identification of 
enzymes responsible for this process will provide further information as to how RAs 
regulate gene expressions. 
Sometimes, RA can regulate the expression of some genes lacking RARE. Namely, RA 
regulates the expression of a transcriptional factor, such as Hox1, which regulates that of 
another gene, as illustrated in Figure 4.  
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Some transcriptional factors are produced from some RA-regulated genes (gene 1). When the 
transcriptional factor binds to the binding site on another gene (gene 2), its transcription starts and 
protein 2 is produced. In this case, protein 2 is thought to be RA regulated.  
Fig. 4. Regulation of gene transcription by RA (2).  
The transcription of some genes is regulated by polycomb group proteins (PcG, Simon and 
Kingston 2009). Although it is still unclear how PcGs recognize their specific sites on DNA, 
they bind to some regions on their target gene. In this situation, co-activators, such as the 
pCIP/p300 protein, can not bind to retinoid receptors binding to the gene, and gene 
translation does not occur. Gillespie and Gudas demonstrated that RA regulates this PcGs-
DNA binding. Namely, when RA binds to the RAR-RXR complex, which binds to RARE 
sometimes located at the 3’ region of the gene, PcGs are removed from the gene, facilitating 
the binding of the gene co-activator(s), starting gene transcription (Figure 5). They 
demonstrated that the RARγ−RXR-RA complex exclusively exhibits such an action, but not 
others. Expressions of Cyp26a1, and RARβ2 are known to be controlled in this way 
(Gillespie and Gudas 2007).  
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Transcription of some genes is regulated by RA via the polycomb group proteins (PcGs) status. In such 
a gene, transcription does not occur without RA since PcGs binding to the gene inhibit its transcription 
(a). However, when RA makes a complex with its receptor, and the complex binds to the RARE of the 
gene which is usually located at its 3’ region, PcGs are removed from the gene, allowing the binding of 
co-factors to the gene via the retinoid receptor, and its transcription starts (b). (modified from a figure 
from Gillespie and Gudas 2007) 
Fig. 5. Regulation of gene transcription by RA via PcGs.  
5. Retinoids and cancer  
When vitamin A, a major source of RAs, is depleted, metaplasia of squamous cells occurs 
(Harris et al. 1972,Lotan et al. 1993). In clinical cases, vitamin A deficiency has been 
implicated in the development of esophageal cancer (Mellow et al. 1983). In vitro studies 
clearly demonstrated that retinoids inhibit cell proliferation of normal cells (Lee et al. 1995). 
The current consensus is that normal differentiation and proliferation of the cell are spoiled 
when intercellular homeostasis of retinoids is disturbed (Zou et al. 1994). Apparently, an 
abnormal retinoid status is related to carcinogenesis. Therefore, it is not surprising that the 
administration of retinoid prevents the development of squamous cell carcinoma in the skin, 
oral cavity, and lung in animal models (Moon et al. 1994). Notably, some synthetic retinoids 
were reported to be effective in preventing the development of esophageal cancer from 
severe esophageal squamous dysplasia (Han 1993).  
Retinoids also act against malignant cells. They suppress the growth rate of various tumor 
cells including melanoma, neuroblastoma, glioma, retinoblastoma, embryonal carcinoma, 
lymphoma, leukemia, myeloma, various sarcoma, as well as cancers of the breast, prostate, 
bladder, colon, head and neck, and cervix. Most malignancies develop based on the 
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complicated accumulation of various events including genetic alterations, dysregulation of 
cell growth, abnormal cell differentiation, and changes in the phenotype and cell function. 
Retinoids may be involved in all of these steps and usually exhibit anti-cancer effects.  
5.1 Retinoids and apoptosis  
It is well established that retinoids induce apoptosis and cell cycle arrest in some malignant 
cells. All-trans retinoic acid (ATRA) has been known to produce p53 dependent apoptosis in 
promyelocytic leukemia HL-60 cells (Noguchi et al. 1995). Moreover, a synthetic retinoid up-
regulated the expression of p21 (WAF1/CP1), Bax, and Killer/DR5, resulting in cell-cycle 
arrest of the G1 phase and apoptosis in human non-small cell lung cancer cell. These 
phenomena were observed only in cell lines having a wild type of p53, but not in those with 
mutant p53, indicating that they were p53 dependent (Sun et al. 1999a). On the other hand, 
retinoids were shown to produce cell-cycle arrest of the G0/G1 phase and apoptosis in a p53 
independent manner in human breast cancer cells (Shao et al. 1995). Apoptosis due to 
retinoids via the BCL2 pathway in orbital fibroblasts (Pasquali et al. 2003), via caspase-3 in 
esophageal squamous cells (Wan et al. 2001), and via CPP32-like caspase in lung non-small 
cell carcinoma (Sun et al. 1999b) have been also demonstrated. In addition, c-Myc and its 
downstream genes have been shown to be involved in apoptosis caused by a synthetic 
retinoid in human lung cancer cell (Sun et al. 1999c). The mitogen-activated protein kinase 
(MAPKs) pathway is now recognized as an important cascade regulating the expressions of 
various genes related to apoptosis and cell proliferation. RA also activates MEK-dependent 
ERK2, a member of the MAPK family, and subsequent RB hypophosphorylation, resulting 
in cell differentiation and G0 arrest in the myeloid leukemia cell line (Yen et al. 1998).  
Obviously, retinoids have the potential to produce apoptosis in various cells, resulting in the 
reduction of cell growth. Thus, it is fully conceivable that an RA deficiency causes the 
reduction of cellular apoptosis, which may cause carcinogenesis. Although the mechanisms 
as to how retinoid causes apoptosis have not been unified, differences in experimental 
conditions, including characteristics of target cells, structures of retinoids used, and 
amounts of retinoids used, may account, at least in part, for this complexity.  
5.2 Retinoids and cell differentiation  
Retinoids maintain proper differentiation in normal cells at physiological doses as well as 
restore demolished regulation of differentiation and/or cell growth of certain malignant or 
pre-malignant cells at pharmacological doses. At any rate, they usually enhance cell 
differentiation (Gudas et al. 1994). RA signals via RAR-β2 seem to be responsible for the 
maintenance of normal cell differentiation in epithelial cells. RAR-β2 signals are known to 
suppress the expression of EGFR (or ErbB-1). Thus, its reduction causes over expression of 
EGFR and its downstream proteins comprising activating protein-1 (AP-1) and COX-2, 
resulting in the disturbance of normal cell differentiation. The RAR-β2 signals are also 
known to attenuate the phosphorylation of extracellular signal-regulated protein kinases 1 
and 2 (Erk1/2), contributing to the down-regulation of AP-1 in esophageal cancer cells (Li et 
al. 2002). Recently, a new protein named retinoid receptor induced gene 1 (RRIG1), 
mediating the anticancer effects of RAR-β2, was cloned from esophageal cells. When its 
expression is maintained, the expression of RhoA and its downstream proteins including 
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Cyclin D1, the phosphorylation of Erk1/2, and COX-2 are suppressed. RhoA also causes f-
actin formation which induces colony formation, invasion, and proliferation of cells. 
Suppression of RhoA is required to keep these malignant characteristics in stationary states. 
When RRGI1 expression is attenuated using its antisense mRNA, these malignant 
characteristics were induced in esophageal squamous cancer cell lines (Liang et al. 2006). 
Preservation of cell-cell communication is an important characteristic for maintaining 
normal cell differentiation. Retinoids induce expression of connexin 43, a gap junction 
protein, contributing to the meintenance of cell-cell communication (Rogers et al. 1990). 
Retinoids also participate in the maintenance of gene expression of various extracellular 
matrix proteins, including integrins, lamminin (Ross et al. 1994), and hyaluronic acid (Kim 
et al. 2010) to prevent the transformation of normal cells. RA signals via RAR-β may 
participate in the expression of several cell adhesion proteins, such as LSAMP which has 
anti cancer effects, and PCDH11Y which guides normal development (Wallden et al. 2005). 
5.3 Retinoids and anti cancer effect via immunity  
Retinoids also exhibit anti tumor effects via immunological mechanisms. Treatment of 
tumors with ATRA resulted in increased sensitivity to CTL and NK-cell-mediated lysis via 
MHC class I (Santin et al. 1998, Thompson et al. 2006). ATRA administration was shown 
to enhance apoptosis induced by IFN-γ in human glioblastoma cells. IFN-┛ causes 
expression of HLA class II and HLA-DM molecules, and expression levels become higher 
when cells are treated with ATRA. Apparently, ATRA contributes to the production of 
apoptosis via the class II-mediated immune system (Haque et al. 2007). Recently, 
upregulation of HER2 (or ErbB-2) is implicated in the carcinogenesis of some cancers. 
IFNγ is known to downregulate HER2 oncoprotein p185 and this may be an event 
explaining the anti cancer effect of IFNγ. Ou et al. demonstrated that IFNγ induces the 
expression of RRIG1, which is responsible for the downregulation of the HER2 
oncoprotein p185 in ovarian cancer cells. Thus, retinoids, which are essential factors for 
maintaining RRIG1 expression, should be important in exhibiting the anti-cancer effect of 
IFNγ (Ou et al. 2008). Retinoids exhibit anti cancer effects not only via ErbB-1, as shonw in 
section 5.2, but also ErbB-2.  
RA signals via RAR-β2 have been shown to increase the expression of tumor cell antigens, 
such as CTAG1, CTAG2, and those of RIG-1/DDX58, responsible for the innate immune 
response (Wallden et al. 2005). From this viewpoint, retinoids are also indispensable for the 
anti cancer effect via immunity.  
5.4 Lack of RAR-β2 expression and carcinogenesis  
There is no doubt that RA has anticancer effects, however, some cancers exhibit RA 
resistance (Lippman and Davis 1997). Although the mechanisms behind this phenomenon 
are still obscure, the role of RAR-β2, one of the RA receptor, is of major interest, recently. 
The importance of RAR-β2 signals for anti cancer effects are mentioned in section 5.2 and 
5.3, and recently, the relationship between suppression of RAR-β2 expression and RA 
resistance was demonstrated in various cell lines established from cancers in the kidney, 
esophagus, lung, breast, and prostate. Importantly, when RAR-β2  cDNA is compulsorily 
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expressed using an adequate vector in cancer cells lacking RAR-β2 expression and acquiring 
RA resistance, they regain RA sensitivities (Houle et al. 1993). Furthermore, when COX-2, a 
downstream protein of RAR-β2, was reduced in esophageal cancer cells exhibiting RA 
resistance, they recovered RA sensitivity (Song et al. 2005). On the other hand, when RAR-
β2 expression was compulsorily suppressed by its antisense, lung cancer developed in mice 
(Berard et al.1996). 
In clinical cases, the reduction of RAR-β2 was observed in cancers of head and neck, 
esophagus, lung, breast, pancreas, cervix, and prostate. Interestingly, a lack of RXR-β 
expression is also observed in pre-malignant lesions in the oral cavity (Lotan et al. 1995) 
and the bronchus (Xu et al. 1999), as well as in morphologically normal cells adjacent to 
cancer cells (Widschwendter et al. 1997). It can be assumed that the alteration of RAR-β 
expression status is involved in the neoplastic transformation from normal cells, and these 
aspects are consistent with the concept of field cancerization which was mentioned in 
section 2.3. As also mentioned in section 2.3, where one of characteristic features of field 
cancerization is the accumulation of mutant p53 not only in malignant cells, but also in 
pre-malignant lesions. The reduction of RAR-β2 has been also implicated in the 
accumulation of mutant p53 in some cancers. The accumulation of p53 in pre-malignant 
lesions in the oral cavity has been shown to be correlated with RA resistance, possibly due 
to a lack of RAR−β up-regulation (Lippman et al. 1997). Moreover, immortalized 
dysplastic cells of oral mucosa have been reported to be characterized by the 
accumulation of mutation p53, induction of hTERT mRNA, and a lack of RAR-β2 and p16 
expression (McGregor et al.1997). Consequently, the same group concluded that the lack 
of RAR-β2 and p16 expression are the only essential factors for this transformation 
process among these events, at least for their model (Muntoni et al. 2003).  
Clinically, the preservation of RAR-β2 expression is associated with a higher efficacy in RA 
treatment of premalignant lesions in oral mucosa (Lotan et al. 1995), and also with a better 
prognosis in neuroblastoma cases (Cheung et al. 1998).  
The mechanisms which lie behind the reduction in RAR-β2 expression still remain obscure. 
In a lung cancer cell line lacking RAR-β2 expression, deletion of chromosome 3p, a site 
responsible for RAR-β2, was observed (Geradts et al. 1993). However, this seems to be a rare 
case. On the other hand, Lin et al. found that the orphan receptor COUP-TF was essential for 
RAR-β2 expression and the lack of COUP-TF caused a reduction in RAR-B2 expression in 
some cancers (Lin et al 2000). A recently prevailing view is that the lack of RAR-β2 is 
attributed to epigenetic mechanisms, namely the unusual methylation status of the RAR-β2 
gene, and the aberrant acetylation or phosphorylation of the histone wrapping the gene 
(Widschwendter et al. 2000, Lewis et al. 2005, Bean et al. 2005). In addition, Lefebvre et al. 
have demonstrated that an alteration of the PI3K/Akt signaling pathway is involved in the 
abnormal phosphorylation of the RAR-β2 histone, resulting in the loss of RAR-β2 expression 
in the cell (Lefebvre et al. 2006).  
Importantly, the genes of RAR-β2 and RRIG1 constituting the RAR-β2 pathway, are RA 
inducible genes. The fact that the expression of RAR-β2 is regulated by RA via PcGs is 
mentioned in section 4.2. This suggests that cellular RA levels affect the expression of RAR-
β2 levels and the status of its downstream proteins. The reduction in RAR-β2 expression has 
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been demonstrated in some tissues of rats fed with vitamin A deficient diet (Verma et al. 
1992). Moreover, Xu et al. found that intercellular RA levels were lower in premalignant 
lesions of human oral mucosa compared to normal ones (Xu et al. 1995). These observations 
support the view that an RA deficiency causes the reduction in RAR-β2 expression, which is 
closely related to carcinogenesis. (This section (5.4) was written referring to the review of Xu 
et al., 2007).  
 
RAR-b2↓ lack of orphan   
receptor
EGFR ↑ Retinoid receptor 
induced gene-1 (RRIG1) ↓
Erk1/2 phosphorylation ↑ RhoA activation ↑
COX2 ↑ Cyclin D1↑
carcinogenesis 
f-actin formation ↑
colony formation ↑
invasion ↑
proliferation ↑
accumulation 
of mutant p53
AP-1 ↑
gene deletion      
RA depletion 
epigenetic factors 
 
 
Reduction in RAR-β2 is now assumed to be closely related to carcinogenesis in some organs. In addition, 
the reduction of RAR-β2 is also implicated in the accumulation of mutant P53, which is often observed in 
some cancer cells and their premalignant regions. Multiple factors may affect RAR-β2 expression. Since 
RAR-β2 and RRIG1 are RA inducible genes, RA depletion is expected to reduce their expression, changing 
the features of their downstream proteins. A decrease in the RAR−β2 signal increases expression of EGFR, 
and phosporylation of Erk1/2, resulting in an increase in the expressions of AP-1 and COX-2. It also 
decreases the expressions of RRIG1, resulting in increases in RhoA and Cyclin D1. An increase in RohA 
also causes Erk1/2 phosphorylation and COX2 activation. These changes cause carcinogenesis. In addition, 
RhoA is implicated in the activation of f-actin formation, resulting in colony formation, proliferation, and 
invasion of cells. (modified from a figure from Xu et al. 2007)  
Fig. 6. Possible mechanisms for the development of cancer by RA depletion via a  reduction 
in RAR-β2 expression.  
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6. Structural and functional features of the in situ RA supply system in 
esophageal mucosa and its implication with the clinical aspects of 
esophageal cancer in alcoholics  
As mentioned above, RAs are produced from vitamin A (retinol) in RA target cells in situ via 
a two step oxidation process, namely retinol is oxidized to retinal, a type of aldehyde, then 
retinal is oxidized to RA, a type of acid. The structural feature of this pathway is 
fundamentally the same as that of ethanol metabolism, in which ethanol is oxidized to 
acetaldehyde, a type of aldehyde, then acetaldehyde is oxidized to acetate, a type of acid. It 
is well established that the former pathway comprises retinol dehydrogenase (RDH) and 
retinal dehydrogenase (RalDH), and the latter alcohol dehydrogenase (ADH) and 
aldehydedehydrogenase (ALDH).  
6.1 Cloning of cDNA and gene of ADH7  
Notably, there are several enzymes that have affinity for both retinol and ethanol or retinal 
and acetaldehyde and contribute to their oxidations such as human ADH 7, corresponding 
to Class IV ADH in rat. A study on the interaction between the metabolism of retinol and 
ethanol was opened by the findings of the existence of such enzymes. We cloned the cDNA 
(Yokoyama et al. 1994) of human ADH7 from a human gastric cDNA library and showed 
that it had 72% homology to human ADH1, a major ADH, on the cDNA level. We also 
cloned its gene and demonstrated that it was localized at 4q23-24 of the human genome, i.e. 
the ADH cluster (Yokoyama et al. 1996). These observations support the view that the 
enzyme is a member of the ADH family. We also found that the mRNA of ADH7 was 
exclusively expressed in human gastric mucosa among organs examined at that time 
(Yokoyama et al. 1995a). At present, ADH7 is known to be generally expressed in human 
upper digestive organs (Yin et al. 1993). We also reported SNP of ADH7 at exon 7 
(Yokoyama et al. 1995b), however, its significance is still unknown. Recently, SNP at codon 
92 of ADH7 cDNA (glycine/alanine change rs1573496) has been implicated in a higher 
incidence of head and neck cancer (Hashibe et al. 2008).  
6.2 RA supply from vitamin A in the gastrointestinal tract 
To know the significance of ADH7, we examined retinol metabolism in the esophagus and 
stomach using a high pressure liquid chromatography (HPLC) system by which 3 isoforms, 
i.e. all-trans, 9-sis and 13-cis of retinol, retinal, and RA were simultaneously quantified 
(Yokoyama et al. 2000). Subsequently, we established a new HPLC condition to quantify 
these isoforms more precisely (Miyagi et al. 2001, Figure 7). Using this technique, we 
demonstrated that RA could be produced when specimens of rat esophageal mucosa (Crabb 
et al. 2001) and human gastric mucosa (Yokoyama et al. 2001) were incubated with all-trans 
retinol in the presence of NAD. These pathways were designated as NAD-dependent in situ 
RA supply systems. Levels of RA production from retinol were shown to be dependent on 
ADH7 activities in human gastric mucosa (Matsumoto et al. 2001). We also demonstrated 
that Helicobacter pylori infection decreased the levels of ADH7 activities as well as the 
activity levels were inversely associated with the severity of morphological changes in the 
mucosa (Matsumoto et al. 2005).  
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6.3 Feature of an NAD dependent in situ RA supply system in rat esophageal mucosa 
As ADH7, an NAD-dependent enzyme, is expressed in esophageal mucosa and has 
affinity to retinol, the enzyme is expected to contribute to the first step of an NAD-
dependent in situ RA supply system in esophageal mucosa. Since ADH7 also has affinity 
to ethanol, it is postulated that ethanol can hamper the system in a competitive manner. 
When specimens of esophageal mucosa prepared from normal rats were incubated with 
retinol in the presence of NAD and various concentrations of ethanol, ethanol of 1 M or 
more was shown to attenuate RA production in the condition (Shiraishi-Yokoyama et al., 
2003). The ethanol concentration which hampered the RA supply was comparable to the 
established Km value for ethanol of rat Class IV ADH, i.e. at a molar level (Allali-Hassani 
et al., 1996), RA production was thought to be competitively disturbed in the model 
(Shiraishi-Yokoyama et al., 2003).  
 
(1) 13-cis retinal, (2) 9-cis retinal, (3) all-trans retinal, (4) 13-cis RA, (5) 9-cis RA, (6) all-trans RA, (7) 
internal-standard, (8) 13-cis retinol, (9) all-trans retinol (10) all-trans 4-oxo RA, (11) 9-cis 4-oxo RA, (12) 
13-cis 4-oxo RA. Various retinoid isoforms were successfully separated using a HPLC technique 
established in our laboratory. It allowed us to quantify them up to 2.5 ng/ml. The details are described 
in the article of Miyagi et al. 2001.   
Fig. 7. Simultaneous quantification of various retinoids by a HPLC technique.  
Using a similar experimental design, we also found that acetaldehyde of 50 µM  and more 
hampered RA production from retinal in the esophageal mucosa of the rat, suggesting that an 
enzyme having affinity to both acetaldehyde and retinal participates in the second step of the 
NAD dependent in situ RA supply system in esophageal mucosa (Shiraishi-Yokoyama et al. 
2006). One of the candidates having such characteristics was ALDH1A1, and this assumption 
was supported by our observation  that the acetaldehyde concentration that hampered RA 
supply in the model was comparable to the reported Km value for acetaldehyde of rat 
ALDH1A1, i.e. 30 µM (Crabb et al., 2004). This also supports the view that RA production was 
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competitively disturbed by acetaldehyde. The finding that catalytic activity for all-trans retinal 
of rat esophageal mucosa was 5.3 µM/min, which  was consistent with that of rat ALDH 1A1 
for all-trans retinal, i.e, 0.6-10 µM (Kathmann et al., 2000; Montplaisir et al., 2002), also 
suggested that RA production in the model was due to ALDH1A1.  
We recently demonstrated that predominant ADHs in rat esophageal mucosa were Class I, 
III, and IV ADHs in mRNA levels (Yokoyama et al. 2010), which agreed with the expression 
pattern of ADHs in rat esophageal mucosa as examined in protein levels (Vaglenova et al. 
2003). As Class IV ADH exhibits the highest affinity for retinol among these ADHs (Moreno 
and Pares, 1991), the view that Class IV ADH is involved in the NAD-dependent in situ RA 
supply system in rat esophageal mucosa is plausible. Moreover, we also demonstrated that 
the predominant ALDHs in rat esophageal mucosa were ALDH 1A1 and 3A1 in mRNA 
levels (Yokoyama et al. 2010). Since ALDH1A1 has the potential for catalyzing retinal to RA, 
whereas ALDH3A1 has no affinity for retinal (Yoshida et al., 1992, Bhat et al., 1996, Moore et 
al., 1998), this finding is compatible with the view that ALDH1A1 constitutes the NAD-
dependent in situ RA supply system in rat esophageal mucosa.  
We also confirmed that the expression levels of mRNA of both Class IV ADHs and ALDH 
1A1 in the mucosal-layer of the rat esophagus were significantly higher than those in its 
muscle-layer (Yokoyama et al. 2010). Similar observations for Class IV ADH in the 
esophagus (Haselback and Duester, 1997, Vaglenova et al., 2003) and ALDH1A1 in the 
alveolar wall (Hind M et al., 2002) were reported. It is likely that the NAD-dependent RA 
supply system predominantly exists in the mucosal-layer, compared to the muscle-layer, in 
the rat esophagus and is supposed by the fact that a large quantity of RA is required in the 
epidermis compared to muscle (Randolph and Siegenthaler, 1999).  
6.4 An NAD dependent in situ RA supply system in human esophageal mucosa  
Since the expression pattern of isoforms of ADHs and ALDHs in human esophageal 
mucosa (Yin et al. 2003) is identical to that of the rat, it is postulated that an NAD-
dependent in situ RA supply system whose structural feature is similar to that of rat 
esophageal mucosa exists in human esophageal mucosa, and responsible enzymes for the 
pathway are expected as ADH7 and ALDH1A, corresponding to rat Class IV ADH and 
ALDH1A1, respectively. When it is premised on this assumption, various clinical 
characteristics of esophageal cancers seen in alcoholics can be explained fairly 
satisfactorily.  
The Km value for ethanol of human ADH7 is 25mM (Kedishvili et al., 1995), markedly 
different from that of rat Class IV ADH. Since this ethanol level habitually appears in 
alcoholics, the first step of the NAD-dependent in situ RA supply system in the human 
esophagus could be hampered, causing a reduction in RA supply in them. It is of interest to 
know the effect of above mentioned ADH7 SNP rs1573496, which is implicated in the higher 
incidence of head and neck cancer (Hashibe et al. 2008), on RA supply. On the other hand, 
the Km value for acetaldehyde of human ALDH1 is 41 µM (Kathmann et al., 2000), 
comparable to that of rat ALDH1A1. Importantly, acetaldehyde of such a level actually 
appears in alcoholics with the ALDH 2*2 allele. This suggests that the second step of the 
NAD-dependent in situ RA supply system in the human esophagus is further hampered in 
such subjects (Figure 8).  
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Retinol                                         Ethanol 
ADH 7     Km for Ethanol =25 mM 
Retinal                                     Acetaldehyde 
ALDH1   Km for acetaldehyde = 41 µM 
Retinoic acid                                     Acetate   
The in situ RA supply system in human esophageal mucosa may comprise ADH7 and ALDH1. Since 
they also have affinity for ethnaol and acetaldehyde, respectively, the system may also participate in 
ethanol metabolism. Considering their Km values for ethanol and acetaldehyde, when esophagus is 
exposed to ethanol at a concentration of more than 25 mM, and acetaldehyde at a concentration of more 
than 41 µM, which can occur in alcoholics and in alcoholics with the ALDH2*2 allele, respectively, RA 
supply from retinol is hampered, resulting in the development of a RA deficiency. Importantly, 
multiple lines of evidence suggest that a RA deficiency causes carcinogenesis.  
Fig. 8. Metabolism of retinol and ethanol via the in situ RA supply system in human 
esophageal mucosa.  
6.5 Features of the in situ RA supply system in esophageal mucosa and clinical 
aspects of esophageal cancers related to ethanol consumption 
In this chapter, the relationship between RA and carcinogenesis is summarized and we refer 
to the possibility that an intracellular RA deficiency leads to  carcinogenesis. On the other 
hand, our observations that an NAD dependent in situ RA supply system comprising Class 
IV ADH and ALDH1A1 exists and ethanol metabolism hampers RA supply in rat 
esophageal mucosa are introduced. Moreover, we mention the plausibility that human 
esophageal mucosa also has a similar system comprising ADH7 and ALDH1A. 
Incorporating these views, our hypothesis is that RA supply in esophageal mucosa is 
hampered by excessive ethanol consumption and this is a causative factor in the 
development of esophageal cancer in alcoholics. In this section, whether this hypothesis can 
fit with the clinical characteristics of esophageal cancer in alcoholics is discussed.  
6.5.1 The in situ RA supply system and organ specificities in cancers related to 
ethanol consumption 
As mentioned in section 2.1, there are organ specificities in cancers related to ethanol 
consumption. The present hypothesis suggests that the in situ RA supply system in 
esophageal mucosa comprises ADH7 and ALDH1A, and ethanol metabolism hampers these 
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enzymes, resulting in a compromised intracellular RA level and the development of 
malignancy. It must be noted that this hypothesis can be applied to organs comprising RA 
target cells but not to those comprising non RA target cells. Moreover, several enzymes 
which have affinities for retinol and/or retinal but not for ethanol and/or acetaldehyde, 
such as families of p450, RDH, and retinal dehydrogenase (Lee et al. ,1991; Drager et al., 
1998) has been identified. The present hypothesis can be neither applied to organs of which 
in situ RA supply systems comprise such enzymes since ethanol metabolism does not 
disturb RA supply in them. Thus, organ specificity of the structural feature of the in situ RA 
supply system may, at least in part, account for the organ specific susceptibilities to 
malignancy caused by ethanol consumption.  
6.5.2 The in situ RA supply system and genetic variations in cancers related to 
ethanol consumption 
In section 6.4, we discussed the possibility that ethanol and acetaldehyde of physiological 
concentrations may hamper the NAD-dependent in situ RA supply system in the human 
esophagus. This indicates that ethanol hampers RA supply via this system and 
acetaldehyde further affects it. This schema is compatible with the clinical feature that 
prevalence of esophageal cancer increases in alcoholics and is even higher in alcoholics 
carrying ALDH2*2 allele (Yokoyama et al. 1996), as described in section 2.2. A recently 
prevailing explanation as to how acetaldehyde causes esophageal cancer is that 
acetaldehyde binds to DNA and/or chromatin, forming an acetaldehyde adduct, thereby 
altering their functions (Yu et al. 2011). However, no distinct difference has been 
confirmed between esophageal cancers which develop in alcoholics with or without 
acetaldehyde accumulation, namely in those with or without the ALDH2*2 allele, 
suggesting that the esophageal cancers which develop in both types of alcoholics have a 
common pathogenesis. Thus, the hypothesis that both ethanol and acetaldehyde hamper 
the in situ RA supply system, causing carcinogenesis, is easier to accept than that a 
specific effect of acetaldehyde causes carcinogenesis.  
6.5.3 The in situ RA supply system and field cancerization in cancer related to ethanol 
consumption  
As emphasized in section 5.4, the reduction in RAR-β2 gene expression has been  shown to 
be related to carcinogenesis in various organs, including the esophagus. Furthermore, as 
mentioned in section 4 and 5, RA deficiency may cause this reduction in RAR-β2 expression. 
Interestingly, a significant overlap is observed between cancers related to a lack of RAR-β2 
expression and those related to excessive alcohol consumption, as recognized by IARC 
(Table 1). This overlap is consistent with the present hypothesis that ethanol consumption 
disturbs the in situ RA supply system, resulting in the reduction of RAR-β2 expression and 
carcinogenesis. As mentioned in section 2.3, some types of cancers in the esophagus develop 
via field cancerization. One of the distinct features of the field  cancerization is the 
accumulation of mutant p53 not only in cancer cells, but also pre-malignant lesions. Such 
features were recently demonstrated in the esophageal mucosa of alcoholics (Yokoyama et 
al. 2011). As mentioned in section 5.4, the lack of RAR-β2 expression has been implicated in 
the development of field cancerization as well as in p53 accumulation.  
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Cancers related to RAR−β2 suppresion 
(from statements of Xu et al. 2007) 
Cancers related to alcohol consumption 
(from statements of Bann et al. 2007) 
 Oral cavity   Oral cavity  
 Head and neck   Head and neck  
 Esophagus   Esophagus  
 Brest   Brest  
 Lung   
 Pancreas   
 Prostate  
  Liver  
  Colon and rectum  
Table 1. Cancers related to RAR-β2 suppression and alcohol consumption.  
6.5.4 The in situ RA supply system and strain difference in susceptibility to ethanol 
with respect to carcinogenesis  
As mentioned in section 2.4, thus far, there are limited animal models in which cancers were 
produced by ethanol administration alone. Although Soffritti et al. could produce multiple 
cancers in rats by ethanol administration for long periods (Soffritti et al. 2002), there was 
limited development of esophageal cancer in their model. Since the Km value for ethanol of 
rat Class IV ADH is a  non-physiological level and accumulation of acetaldehyde does not 
usually occur in rats, it is expected that ethanol consumption does not hamper the in situ RA 
supply system in the esophageal mucosa of the rat and this can explain why ethanol alone 
does not produce esophageal cancer in their model. The structural feature of the in situ RA 
supply system may also account for the strain difference in susceptibility to ethanol with 
respect to carcinogenesis.  
7. Conclusion  
There is much evidence to show that reduction of RAs is associated with the development of 
malignancy. Most cancers must develop via multiple processes including genetic alterations, 
dysregulation of cell growth, differentiation, cell function, and cell loss, and change of cell 
phenotype, and RAs are involved in all these events. Furthermore, the reduction of RAs 
may down-regulate immune mechanisms against malignant cells. Among the multiple 
effects of RA, the relationship between the reduction of signals via RAR−β2, one of the RA 
receptors, and carcinogenesis is of major interest lately. The current observations suggest 
that RA deficiency may reduce the expression of RAR-β2.  
In mammals, RA is synthesized from retinol, a type of alcohol, ingested from food. 
Recently, it has become clear that RA can be synthesized from retinol, which is delivered 
by blood vessels, via a two step oxidation pathway in a RA target cell. We recently 
demonstrated that such a pathway which can produce RA from retinol in an NAD 
dependent manner exists in rat esophageal mucosa, and designated it as an NAD 
dependent in situ RA supply system. Furthermore, we demonstrated that the pathway 
comprised Class IV ADH and ALDH1A1 and was hampered by ethanol, a substance of 
the former as well as by acetaldehyde, that of the latter. Considering the expression 
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patterns of ADH and ALDH in the human and rat esophagus, it is fully plausible that a 
similar pathway, one comprising ADH7 and ALDH1A exists in human esophageal 
mucosa. Since their Km values for ethanol and acetaldehyde are at physiological 
concentrations, we hypothesized that the metabolism of excessive  ethanol consumption 
disturbs the pathway, resulting in a deficiency in RA, and the development of malignancy 
in esophageal mucosa. This hypothesis can account for clinical characteristics of cancers in 
alcoholics, including organ specificity, genetic specificity, and strain specificity. Moreover, 
this hypothesis is also compatible with the fact that esophageal cancer develops in a field 
cancerization manner in alcoholics. Further studies based on this hypothesis may be 
beneficial for understanding the pathogenesis of esophageal cancer seen in alcoholics, 
which must be important for having strategies of its prevention, diagnosis and treatment.  
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